Activity of Belinostat in patients with recurrent or refractory peripheral or cutaneous T-cell lymphoma. Hematology Meeting Reports, [S. l.], v. 3, n. 1, 2009. DOI: 10.4081/hmr.v3i1.527. Disponível em: https://journals.pagepress.net/hmr/article/view/527. Acesso em: 2 jun. 2026.